THYMOSIN-ALPHA-1 POTENTIATES INTERLEUKIN 2-INDUCED CYTOTOXIC ACTIVITY IN MICE

被引:28
作者
MASTINO, A
FAVALLI, C
GRELLI, S
INNOCENTI, F
GARACI, E
机构
[1] Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata
关键词
D O I
10.1016/0008-8749(91)90191-D
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have investigated the effects of interleukin 2 (IL-2) on cytotoxic activity of spleen lymphocytes, from normal and cyclophosphamide (200 mg/kg) or B-16 melanoma suppressed mice, after in vitro or in vivo pretreatment with thymosin α 1 (TA1). The results of this study indicate that pretreatment in vitro (100 ng/ml for 1 hr) or in vivo (200 μg/kg/day for 4 days) with thymosin α 1 (TA1), significantly increased the IL-2 (from 100 to 500 U/ml) in vitro induced cytotoxic activity of spleen lymphocytes, collected from both normal and cyclophosphamide and tumor-suppressed animals, against both YAC-1 (NK sensitive) and MBL-2 (NK resistant) cell lines. The potential use in combination of these two different biological response modifiers, useful in enhancing the immunological responses to IL-2 of lymphocytes, may provide a novel model of immunotherapeutic intervention in cancer. © 1991.
引用
收藏
页码:196 / 205
页数:10
相关论文
共 34 条
[1]  
COLIZZI V, 1985, IMMUNOLOGY, V56, P653
[2]  
DONOHUE JH, 1984, J IMMUNOL, V132, P2123
[3]  
FAVALLI C, 1985, CANCER IMMUNOL IMMUN, V20, P189
[4]   SYNERGISTIC EFFECT OF THYMOSIN ALPHA-1 AND ALPHA-BETA-INTERFERON ON NK ACTIVITY IN TUMOR-BEARING MICE [J].
FAVALLI, C ;
MASTINO, A ;
JEZZI, T ;
GRELLI, S ;
GOLDSTEIN, AL ;
GARACI, E .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1989, 11 (05) :443-450
[5]   TUMOR-INHIBITION BY INTERLEUKIN-2 AT THE TUMOR HOST INTERFACE [J].
FORNI, G ;
GIOVARELLI, M ;
SANTONI, A ;
MODESTI, A ;
FORNI, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 865 (03) :307-327
[6]  
FORNI G, 1988, RECENT ADV AUTOIMMUN, P179
[7]  
GARACI C, 1990, IN PRESS CANCER IMMU
[8]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .2. PRECURSOR PHENOTYPE IS SEROLOGICALLY DISTINCT FROM PERIPHERAL LYMPHOCYTES-T, MEMORY CYTO-TOXIC THYMUS-DERIVED LYMPHOCYTES, AND NATURAL-KILLER CELLS [J].
GRIMM, EA ;
RAMSEY, KM ;
MAZUMDER, A ;
WILSON, DJ ;
DJEU, JY ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) :884-897
[9]   THERAPEUTIC IMMUNOPHARMACOLOGY [J].
HADDEN, JW .
CURRENT OPINION IN IMMUNOLOGY, 1989, 2 (02) :258-263
[10]  
HADDEN JW, 1988, CANCER DETECT PREV, V12, P537